NCT06570655View on ClinicalTrials.gov

The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

June 20, 2024

Study Completion Date

August 29, 2024

Conditions

Healthy Subjects

Interventions

DRUG

Huperzine A injection

intramuscular

DRUG

Huperzine A injection

intravenous bolus

Trial Locations (1)

310000

Clinical trial institution of the Zhejiang Xiaoshan hospital, Hangzhou

All Listed Sponsors

collaborator

Zhejiang Hospital

OTHER

lead

Wanbangde Pharmaceutical Group Co., LTD

INDUSTRY

NCT06570655 - The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter